Judith Balmaña (Judit Balmaña)

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 31

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

NPJ breast cancer

Cancer discovery

Hospital Vall d'Hebron

Universitat Autònoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Vall d'Hebron

Spain

Senior Clinical Assistant Physician :: Breast Cancer Unit -Oncology Department-

Hospital Vall d'Hebron

Spain

Head :: Head of High Risk and Hereditary Cancer

Dana Farber Cancer Institute

United States

Clinical Research Fellow :: High Risk Clinics Unit

Hospital de la Santa Creu i Sant Pau

Spain

Clinical Assistant :: Department of Medical Oncology

Education History

Universitat Autònoma de Barcelona

Spain

PHD :: School of Medicine

Publications

Nadine M Tung, Charité Ricker, Hans Messersmith, Judith Balmaña, Susan M Domchek, Elena Martinez Stoffel, Khaldoun Almhanna, Banu K Arun, Yanin Chavarri Guerra, Stephanie A Cohen, Deborah Cragun, Katherine D Crew, Michael J Hall, Gregory E Idos, Ghecemy Lopez, Tuya Pal, Sara Pirzadeh-Miller, Colin C Pritchard, Huma Q Rana, Umang Swami, Gregory A Vidal
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Alejandra Rezqallah, Sara Torres-Esquius, Alba Llop-Guevara, Mara Cruellas, María Teresa Martínez Martínez, Marcel Romey, Carsten Denkert, Violeta Serra, Isabel Chirivella, Judith Balmaña
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing. JCO precision oncology 8 (2024)
Nadine M Tung, Charité Ricker, Hans Messersmith, Judith Balmaña, Susan M Domchek, Elena Martinez Stoffel, Khaldoun Almhanna, Banu K Arun, Yanin Chavarri Guerra, Stephanie A Cohen, Deborah Cragun, Katherine D Crew, Michael J Hall, Gregory E Idos, Ghecemy Lopez, Tuya Pal, Sara Pirzadeh-Miller, Colin C Pritchard, Huma Q Rana, Umang Swami, Gregory A Vidal
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Javier Carmona, Elena Chavarria, Kate Donoghue, Christina von Gertten, Petra Oberrauch, Emma Pailler, Giovanni Scoazec, Ruud Weijer, Judith Balmaña, Irene Brana, Cinzia Brunelli, Suzette Delaloge, Marc Deloger, Pierre Delpy, Ingemar Ernberg, Rebecca C Fitzgerald, Elena Garralda, Martin Lablans, Janne Lehtiö, Carlos Lopez, Maialen Fernández, Rosalba Miceli, Paolo G Nuciforo, Raquel Perez-Lopez, Elena Provenzano, Marjanka K Schmidt, Cesar Serrano, Neeltje Steeghs, David Tamborero, Valtteri Wirta, Richard D Baird, Karen Barker, Fabrice Barlesi, Michael Baumann, Jonas Bergh, Filippo G De Braud, Karim Fizazi, Stefan Fröhling, Alejandro Piris-Giménez, Kenneth Seamon, Michiel S Van Der Heijden, Wilbert Zwart, Josep Tabernero
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally. Cancer discovery 14 (7) (2024)
Javier Carmona, Elena Chavarria, Kate Donoghue, Christina von Gertten, Petra Oberrauch, Emma Pailler, Giovanni Scoazec, Ruud Weijer, Judith Balmaña, Irene Brana, Cinzia Brunelli, Suzette Delaloge, Marc Deloger, Pierre Delpy, Ingemar Ernberg, Rebecca C Fitzgerald, Elena Garralda, Martin Lablans, Janne Lehtiö, Carlos Lopez, Maialen Fernández, Rosalba Miceli, Paolo G Nuciforo, Raquel Perez-Lopez, Elena Provenzano, Marjanka K Schmidt, Cesar Serrano, Neeltje Steeghs, David Tamborero, Valtteri Wirta, Richard D Baird, Karen Barker, Fabrice Barlesi, Michael Baumann, Jonas Bergh, Filippo G De Braud, Karim Fizazi, Stefan Fröhling, Alejandro Piris-Giménez, Kenneth Seamon, Michiel S Van Der Heijden, Wilbert Zwart, Josep Tabernero
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally. Cancer discovery (2024)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Ana Beatriz Sanchez-Heras, Teresa Ramon Y Cajal, Marta Pineda, Elena Aguirre, Begoña Graña Suarez, Isabel Chirivella, Judith Balmaña, Joan Brunet, null null
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Nicholas C Turner, A Douglas Laird, Melinda L Telli, Hope S Rugo, Audrey Mailliez, Johannes Ettl, Eva-Maria Grischke, Lida A Mina, Judith Balmaña, Peter Andreas Fasching, Sara Alsterlind Hurvitz, Julia F Hopkins, Lee A Albacker, Jijumon Chelliserry, Ying Chen, Umberto Conte, Andrew M Wardley, Mark E Robson
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study. NPJ breast cancer 9 (1) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Nasim Mavaddat, Lorenzo Ficorella, Tim Carver, Andrew J Lee, Alex P Cunningham, Michael Lush, Joe G Dennis, Marc Tischkowitz, Kate Downes, Donglei Hu, Eric Hahnen, Rita K Schmutzler, Tracy L Stockley, Gregory S Downs, Tong Zhang, Anna M Chiarelli, Stig Egil Bojesen, Cong Liu, Wendy K Chung, Monica Pardo, Lidia Feliubadaló, Judith Balmaña, Jacques Simard, Antonis C Antoniou, Douglas F Easton
Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Cristina Saura, Carolina Ortiz, Judit Matito, Enrique J Arenas Lahuerta, Anna Suñol, Ágatha Martín, Octavi Córdoba, Alex Martínez-Sabadell, Itziar Garcia-Ruiz, Ignacio Miranda, Clara Morales-Comas, Estela Carrasco, Cristina Viaplana, Vicente Peg, Paolo G Nuciforo, Neus Bayó-Puxan, Alberto Gonzalez-Medina, Josep M Miquel, Marina Gómez-Rey, Guillermo Villacampa, Silvia A Martínez, Martín Espinosa-Bravo, Judith Balmaña, Rodrigo Dienstmann, Joaquín Arribas, Josep Tabernero, Ana Vivancos, Miriam Sansó
Early-Stage Breast Cancer Detection in Breast Milk. Cancer discovery (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Adrià López-Fernández, Guillermo Villacampa, Mònica Salinas, Elia Grau, Esther Darder, Estela Carrasco, Ares Solanes, Angela Velasco, Maite Torres, Elisabet Munté, Silvia Iglesias, Sara Torres-Esquius, Noemí Tuset, Orland Diez, Conxi Lázaro, Joan Brunet, Sergi Corbella, Judith Balmaña
Role of psychological background in cancer susceptibility genetic testing distress: It is not only about a positive result. Journal of genetic counseling (2023)
Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, Flaminia Pedretti, Alejandro Moles-Fernández, Cristina Viaplana, Guillermo Villacampa, Marta Guzmán, Olga Rodríguez, Judit Grueso, Jose Jiménez, Enrique J Arenas, Andrea Degasperi, Joao M L Dias, Josep V Forment, Lenka Oplustil O'Connor, Olivier Déas, Stefano Cairo, Yinghui Zhou, Antonino Musolino, Carlos Caldas, Serena Nik-Zainal, Robert B Clarke, Paolo G Nuciforo, Orland Díez, Xavier Serres-Créixams, Vicente Peg, Martín Espinosa-Bravo, Teresa Macarulla, Ana Oaknin, Joaquin Mateo, Joaquín Arribas, Rodrigo Dienstmann, Meritxell Bellet-Ezquerra, Mafalda Oliveira, Cristina Saura, Sara Gutiérrez-Enríquez, Judith Balmaña, Violeta Serra
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification. Cancer research 82 (8) (2022)
Jennifer B Shah, Dana Pueschl, Bradley Wubbenhorst, Mengyao Fan, John Pluta, Kurt D'Andrea, Anna P Hubert, Jake S Shilan, Wenting Zhou, Adam A Kraya, Alba Llop Guevara, Catherine Ruan, Violeta Serra, Judith Balmaña, Michael Feldman, Pat J Morin, Anupma Nayak, Kara N Maxwell, Susan M Domchek, Katherine L Nathanson
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. Nature communications 13 (1) (2022)
Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, Urszula M Polanska, Marta Palafox, Andrea Herencia-Ropero, Gemma N Jones, Zhongwu Lai, Joshua Armenia, Filippos Michopoulos, Alba Llop-Guevara, Rachel Brough, Aditi Gulati, Stephen J Pettitt, Krishna C Bulusu, Jenni Nikkilä, Zena Wilson, Adina M Hughes, Paul W G Wijnhoven, Ambar Ahmed, Alejandra Bruna, Albert Gris-Oliver, Marta Guzman, Olga Rodríguez, Judit Grueso, Joaquín Arribas, Javier Cortes, Cristina Saura, Alan Lau, Susan E Critchlow, Brian Dougherty, Carlos Caldas, Gordon B Mills, J Carl Barrett, Josep V Forment, Elaine B Cadogan, Christopher J Lord, Cristina Cruz, Judith Balmaña, Lenka Oplustil O'Connor
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
David Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, Jorrit Boekel, Adrià López-Fernández, Markus Jonsson, Ali Razzak, Irene Braña, Luigi De Petris, Jeffrey Yachnin, Richard D Baird, Yohann Loriot, Christophe Massard, Patricia Martin-Romano, Frans Opdam, Richard F Schlenk, Claudio Vernieri, Michele Masucci, Xenia Villalobos, Elena Chavarria, null null, Judith Balmaña, Giovanni Apolone, Carlos Caldas, Jonas Bergh, Ingemar Ernberg, Stefan Fröhling, Elena Garralda, Claes Karlsson, Josep Tabernero, Emile E Voest, Jordi Rodon, Janne Lehtiö
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. Nature cancer 3 (2) (2022)
Marta Codina-Solà, Laura Trujillano, Anna Abulí, Eulàlia Rovira-Moreno, Patricia Muñoz-Cabello, Berta Campos, Paula Fernández-Álvarez, Dolors Palau, Estela Carrasco, Maria Irene Valenzuela Palafoll, Anna Maria Cueto-González, Amaia Lasa-Aranzasti, Javier Limeres Freire, Jordi Leno-Colorado, Mar Costa-Roger, Alejandro Moles-Fernández, Judith Balmaña, Orland Díez, Ivon Cuscó, Elena Garcia-Arumí, Eduardo Fidel Tizzano
An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family history. European journal of human genetics : EJHG (2022)
Estela Carrasco, Adrià López-Fernández, Marta Codina-Sola, Irene Valenzuela, A M Cueto-González, Guillermo Villacampa, Victor Navarro, Sara Torres-Esquius, Dolors Palau, Mara Cruellas, Maite Torres, Belen Perez-Dueñas, Anna Abulí, Orland Diez, Constantino Sábado-Álvarez, Elena García-Arumí, Eduardo F Tizzano, Lucas Moreno, Judith Balmaña
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders. Journal of medical genetics (2022)
Laia Castells-Roca, Sara Gutiérrez-Enríquez, Sandra Bonache, Massimo Bogliolo, Estela Carrasco, Miriam Aza-Carmona, Gemma Montalban, Núria Muñoz-Subirana, Roser Pujol, Cristina Cruz, Alba Llop-Guevara, María J Ramírez, Cristina Saura, Adriana Lasa, Violeta Serra, Orland Diez, Judith Balmaña, Jordi Surralles
Clinical consequences of BRCA2 hypomorphism. NPJ breast cancer 7 (1) (2021)
Nicholas C Turner, Judith Balmaña, Coralie Poncet, Theodora Goulioti, Konstantinos Tryfonidis, Aafke H Honkoop, Gabriele Zoppoli, Evangelia D Razis, Oskar T Johannsson, Marco Colleoni, Andrew N J Tutt, William Audeh, Michail Ignatiadis, Audrey Mailliez, Olivier Trédan, Antonino Musolino, Peter Vuylsteke, Maria Jose Juan-Fita, Iain R J Macpherson, Bella Kaufman, Luis Manso, Lori J Goldstein, Susan L Ellard, István Láng, Kai Yu Jen, Virginie Adam, Saskia Litière, John Erban, David A Cameron, null null
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Matteo Lambertini, Marcello Ceppi, Anne Sophie Hamy, Olivier Caron, Philip D Poorvu, Estela Carrasco, Albert Grinshpun, Kevin Punie, Christine Rousset-Jablonski, Alberta Ferrari, Shani Paluch-Shimon, Angela Toss, Claire Senechal, Fabio Puglisi, Katarzyna Pogoda, Jose Alejandro Pérez-Fidalgo, Laura De Marchis, Riccardo Ponzone, Luca Livraghi, Maria Del Pilar Estevez Diz, Cynthia Villarreal Garza, Maria Vittoria Dieci, Florian Clatot, Fran Ois P Duhoux, Rossella Graffeo, Luis Teixeira, Octavi Córdoba, Amir Sonnenblick, Arlindo R Ferreira, Ann H Partridge, Antonio Di Meglio, Claire Saule, Fedro Alessandro Peccatori, Marco Bruzzone, Marie Daphne t'Kint de Roodenbeke, Lieveke Ameye, Judith Balmaña, Lucia Del Mastro, Hatem A Azim
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants. NPJ breast cancer 7 (1) (2021)
Adrià López-Fernández, Guillermo Villacampa, Elia Grau, Mónica Salinas, Esther Darder, Estela Carrasco, Sara Torres-Esquius, Silvia Iglesias, Ares Solanes, Neus Gadea, Angela Velasco, Gisela Urgell, Maite Torres, Noemí Tuset, Joan Brunet, Sergi Corbella, Judith Balmaña
Patients' and professionals' perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic. Genetics in medicine : official journal of the American College of Medical Genetics 23 (8) (2021)
Lídia Feliubadaló, Adrià López-Fernández, Marta Pineda, Orland Díez, Jesús Del Valle, Sara Gutiérrez-Enríquez, Alex Teulé, Sara González, Neda Stjepanovic, Mónica Salinas, Gabriel Capellá, Joan Brunet, Conxi Lázaro, Judith Balmaña, null null
Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels. International journal of cancer 145 (10) (2019)
Marta Castroviejo-Bermejo, Cristina Cruz, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, Mandy Ducy, Yasir Hussein Ibrahim, Albert Gris-Oliver, Benedetta Pellegrino, Alejandra Bruna, Marta Guzmán, Olga Rodríguez, Judit Grueso, Sandra Bonache, Alejandro Moles-Fernández, Guillermo Villacampa, Cristina Viaplana, Patricia Gómez, Maria Vidal, Vicente Peg, Xavier Serres-Créixams, Graham Dellaire, Jacques Simard, Paolo Nuciforo, Isabel T Rubio, Rodrigo Dienstmann, J Carl Barrett, Carlos Caldas, José Baselga, Cristina Saura, Javier Cortés, Olivier Déas, Jos Jonkers, Jean-Yves Masson, Stefano Cairo, Jean-Gabriel Judde, Mark J O'Connor, Orland Díez, Judith Balmaña, Violeta Serra
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. EMBO molecular medicine 10 (12) (2019)

Judith Balmaña.css-eqlu8i{font-size:small;padding-left:4px;} (Judit Balmaña)

Publication Activity (10 Years)

Top Topics

Top Venues

Judith Balmaña (Judit Balmaña)